The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE
Background: We previously reported that elevation of intracranial dopamine (DA) levels from cirrhotic livers is implicated in the pathogenesis of minimal hepatic encephalopathy (MHE). Intracellular events in neurons, which lead to memory loss in MHE by elevated DA, however, remain elusive. Methods:...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-11-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/366391 |
_version_ | 1828485619522732032 |
---|---|
author | Saidan Ding Jiangnan Hu Jianjing Yang Leping Liu Weilong Huang Xialong Gu Yiru Ye Lijie Huang Yong Liang Bicheng Chen Qichuan Zhuge |
author_facet | Saidan Ding Jiangnan Hu Jianjing Yang Leping Liu Weilong Huang Xialong Gu Yiru Ye Lijie Huang Yong Liang Bicheng Chen Qichuan Zhuge |
author_sort | Saidan Ding |
collection | DOAJ |
description | Background: We previously reported that elevation of intracranial dopamine (DA) levels from cirrhotic livers is implicated in the pathogenesis of minimal hepatic encephalopathy (MHE). Intracellular events in neurons, which lead to memory loss in MHE by elevated DA, however, remain elusive. Methods: In our present study, an MHE rat model, a DA - intracerebroventricularly (i.c.v.) injected rat model and DA-treated primary cortical neurons (PCNs) were used to study this issue using behavioral tests, double-labeled fluorescent staining, immunoblotting, and semi-quantitative RT-PCR. Results: Cognitive impairment was observed in MHE rats and DA (10 µg, i.c.v.)-treated rats. The levels of DA in the cerebral cortex of both MHE and DA (10 µg)-treated rats were increased. DA conversely modulated the p-JAK2/p-STAT3 levels in PCNs. In accordance, DA downregulated an anacetylcholine-producing enzyme, choline acetyltransferase (ChAT), and desensitized the M1-type muscarinic acetylcholine receptor (M1 mAChR). Furthermore, naringin completely restored cognitive function in MHE/DA (10 µg)-treated models by activating the JAK2/STAT3 axis, paralleling the upregulation of ChAT and sensitization of M1 mAChR. Conclusions: We propose a hypothesis accounting for memory impairment related to MHE: DA-dependent inactivation of the JAK2/STAT3 axis causes memory loss through cholinergic dysfunction. Our findings provide not only a novel pathological hallmark in MHE but also a novel target in MHE therapy. |
first_indexed | 2024-12-11T09:17:59Z |
format | Article |
id | doaj.art-df40296b404346178ccaaee48f77348c |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-12-11T09:17:59Z |
publishDate | 2014-11-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-df40296b404346178ccaaee48f77348c2022-12-22T01:13:20ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782014-11-013461933195010.1159/000366391366391The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHESaidan DingJiangnan HuJianjing YangLeping LiuWeilong HuangXialong GuYiru YeLijie HuangYong LiangBicheng ChenQichuan ZhugeBackground: We previously reported that elevation of intracranial dopamine (DA) levels from cirrhotic livers is implicated in the pathogenesis of minimal hepatic encephalopathy (MHE). Intracellular events in neurons, which lead to memory loss in MHE by elevated DA, however, remain elusive. Methods: In our present study, an MHE rat model, a DA - intracerebroventricularly (i.c.v.) injected rat model and DA-treated primary cortical neurons (PCNs) were used to study this issue using behavioral tests, double-labeled fluorescent staining, immunoblotting, and semi-quantitative RT-PCR. Results: Cognitive impairment was observed in MHE rats and DA (10 µg, i.c.v.)-treated rats. The levels of DA in the cerebral cortex of both MHE and DA (10 µg)-treated rats were increased. DA conversely modulated the p-JAK2/p-STAT3 levels in PCNs. In accordance, DA downregulated an anacetylcholine-producing enzyme, choline acetyltransferase (ChAT), and desensitized the M1-type muscarinic acetylcholine receptor (M1 mAChR). Furthermore, naringin completely restored cognitive function in MHE/DA (10 µg)-treated models by activating the JAK2/STAT3 axis, paralleling the upregulation of ChAT and sensitization of M1 mAChR. Conclusions: We propose a hypothesis accounting for memory impairment related to MHE: DA-dependent inactivation of the JAK2/STAT3 axis causes memory loss through cholinergic dysfunction. Our findings provide not only a novel pathological hallmark in MHE but also a novel target in MHE therapy.http://www.karger.com/Article/FullText/366391Minimal hepatic encephalopathy (MHE)DopamineMemory impairmentJAK2/STAT3 axisM1-type muscarinic acetylcholine receptor (M1 mAChR) |
spellingShingle | Saidan Ding Jiangnan Hu Jianjing Yang Leping Liu Weilong Huang Xialong Gu Yiru Ye Lijie Huang Yong Liang Bicheng Chen Qichuan Zhuge The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE Cellular Physiology and Biochemistry Minimal hepatic encephalopathy (MHE) Dopamine Memory impairment JAK2/STAT3 axis M1-type muscarinic acetylcholine receptor (M1 mAChR) |
title | The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE |
title_full | The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE |
title_fullStr | The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE |
title_full_unstemmed | The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE |
title_short | The Inactivation of JAK2/STAT3 Signaling and Desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the Protection of Naringin Against MHE |
title_sort | inactivation of jak2 stat3 signaling and desensitization of m1 machr in minimal hepatic encephalopathy mhe and the protection of naringin against mhe |
topic | Minimal hepatic encephalopathy (MHE) Dopamine Memory impairment JAK2/STAT3 axis M1-type muscarinic acetylcholine receptor (M1 mAChR) |
url | http://www.karger.com/Article/FullText/366391 |
work_keys_str_mv | AT saidanding theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT jiangnanhu theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT jianjingyang theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT lepingliu theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT weilonghuang theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT xialonggu theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT yiruye theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT lijiehuang theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT yongliang theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT bichengchen theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT qichuanzhuge theinactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT saidanding inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT jiangnanhu inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT jianjingyang inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT lepingliu inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT weilonghuang inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT xialonggu inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT yiruye inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT lijiehuang inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT yongliang inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT bichengchen inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe AT qichuanzhuge inactivationofjak2stat3signalinganddesensitizationofm1machrinminimalhepaticencephalopathymheandtheprotectionofnaringinagainstmhe |